コンテンツへスキップ
Merck
  • Efficacy of ketoprofen vs. ibuprofen and diclofenac: a systematic review of the literature and meta-analysis.

Efficacy of ketoprofen vs. ibuprofen and diclofenac: a systematic review of the literature and meta-analysis.

Clinical and experimental rheumatology (2013-05-29)
Piercarlo Sarzi-Puttini, Fabiola Atzeni, Luigi Lanata, Michela Bagnasco
要旨

The aim of this systematic review of the literature and meta-analysis of randomised controlled trials (RCTs) was to compare the efficacy of orally administered ketoprofen with that of ibuprofen and/or diclofenac. The literature was systematically reviewed in accordance with the Cochrane Collaboration guidelines. The search was restricted to randomised clinical trials published in the Medline and Embase databases up to June 2011, and comparing the efficacy of oral ketoprofen (50-200 mg/day) with ibuprofen (600-1800 mg/day) or diclofenac (75-150 mg/day). A total of 13 RCTs involving 898 patients met the inclusion criteria: eight comparing ketoprofen with ibuprofen, and five comparing ketoprofen with diclofenac. The results of the meta-analysis showed a statistically significant difference in efficacy in favour of ketoprofen. The difference between ketoprofen and the pooled ibuprofen/diclofenac data was also statistically significant (0.459, 95% CI 0.33-0.58; p=0.00) at all point-estimates of the mean weighted size effect. Ketoprofen was significantly superior to both diclofenac (mean = 0.422; 95% CI 0.19-0.65; p=0.0007) and ibuprofen (mean = 0.475; 95% CI 0.32-0.62; p=0.0000) at all point-estimates. Heterogeneity for the analysed efficacy outcome was not statistically significant in any of the meta-analyses. The efficacy of orally administered ketoprofen in relieving moderate-severe pain and improving functional status and general condition was significantly better than that of ibuprofen and/or diclofenac.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
イブプロフェン, ≥98% (GC)
USP
イブプロフェン, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
(S)-(+)-イブプロフェン, ReagentPlus®, 99%
Sigma-Aldrich
ケトプロフェン, ≥98% (TLC)
Supelco
イブプロフェン, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
イブプロフェン
Supelco
ケトプロフェン, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
イブプロフェン 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
USP
ケトプロフェン, United States Pharmacopeia (USP) Reference Standard
Supelco
イブプロフェン ナトリウム塩, ≥98% (GC)
イブプロフェン, European Pharmacopoeia (EP) Reference Standard
イブプロフェン, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
イブプロフェン, meets USP testing specifications
ケトプロフェン, European Pharmacopoeia (EP) Reference Standard
Supelco
ケトプロフェン, VETRANAL®, analytical standard
Sigma-Aldrich
ケトプロフェン, meets USP testing specifications